Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PTN

PTN - Palatin Technologies Inc Stock Price, Fair Value and News

$16.80+0.58 (+3.58%)
Market Closed

48/100

PTN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

48/100

PTN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$16.85

Target 3M

$16.67

Target 6M

$16.72

PTN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PTN Price Action

Last 7 days

3%

Last 30 days

8.0%

Last 90 days

187.2%

Trailing 12 Months

-62.7%

PTN RSI Chart

PTN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PTN Valuation

Market Cap

28.6M

Price/Earnings (Trailing)

-5.95

Price/Sales (Trailing)

10.33

EV/EBITDA

-1.64

Price/Free Cashflow

-1.8

PTN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$16.85

Target 3M

$16.67

Target 6M

$16.72

PTN Fundamentals

PTN Revenue

Revenue (TTM)

4.5M

Rev. Growth (Yr)

92.39%

Rev. Growth (Qtr)

92.39%

PTN Earnings

Earnings (TTM)

-4.8M

Earnings Growth (Yr)

159.79%

Earnings Growth (Qtr)

309.77%

PTN Profitability

Operating Margin

97.83%

EBT Margin

-616.33%

Return on Equity

-1.2K%

Return on Assets

-55.79%

Free Cashflow Yield

-55.62%

PTN Investor Care

Shares Dilution (1Y)

335.51%

Diluted EPS (TTM)

-22.6

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
20245.9M4.5M00
20233.9M4.9M6.1M7.1M
20221.2M1.5M2.2M2.9M
2021343.1K568.1K793.2K1.0M
202015.2M118.0K00
201962.0M60.3M45.3M30.2M
201867.1M67.1M65.4M63.7M
201740.0M67.1M67.1M67.1M
201510.8M13.0M00
2014006.5M8.6M
20132.2M4.3M00
2012424.2K73.7K50.8K45.4K
201101.5M1.1M774.6K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About Palatin Technologies Inc

PTN
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.
 CEO
 WEBSITEhttps://palatin.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES33

Palatin Technologies Inc Frequently Asked Questions

PTN is the stock ticker symbol of Palatin Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Palatin Technologies Inc is 28.6 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PTN's fair value in chart for subscribers.

The fair value guage provides a quick view whether PTN is over valued or under valued. Whether Palatin Technologies Inc is cheap or expensive depends on the assumptions which impact Palatin Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PTN.

As of Wed Jan 28 2026, PTN's PE ratio (Price to Earnings) is -5.95 and Price to Sales (PS) ratio is 10.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PTN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Palatin Technologies Inc has provided -0.301 (multiply by 100 for percentage) rate of return.